Logo image of CMPS

COMPASS PATHWAYS PLC (CMPS) Stock Fundamental Analysis

USA - NASDAQ:CMPS - US20451W1018 - ADR

5.66 USD
+0.21 (+3.85%)
Last: 11/10/2025, 12:34:49 PM
Fundamental Rating

1

CMPS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 531 industry peers in the Biotechnology industry. CMPS has a bad profitability rating. Also its financial health evaluation is rather negative. CMPS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CMPS has reported negative net income.
CMPS had a negative operating cash flow in the past year.
In the past 5 years CMPS always reported negative net income.
CMPS had a negative operating cash flow in each of the past 5 years.
CMPS Yearly Net Income VS EBIT VS OCF VS FCFCMPS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

CMPS has a worse Return On Assets (-92.84%) than 73.82% of its industry peers.
With a Return On Equity value of -631.31%, CMPS is not doing good in the industry: 79.66% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -92.84%
ROE -631.31%
ROIC N/A
ROA(3y)-53.97%
ROA(5y)-43.08%
ROE(3y)-67.74%
ROE(5y)-51.83%
ROIC(3y)N/A
ROIC(5y)N/A
CMPS Yearly ROA, ROE, ROICCMPS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CMPS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CMPS Yearly Profit, Operating, Gross MarginsCMPS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, CMPS has more shares outstanding
CMPS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CMPS is higher compared to a year ago.
CMPS Yearly Shares OutstandingCMPS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CMPS Yearly Total Debt VS Total AssetsCMPS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

CMPS has an Altman-Z score of -4.72. This is a bad value and indicates that CMPS is not financially healthy and even has some risk of bankruptcy.
CMPS has a Altman-Z score of -4.72. This is comparable to the rest of the industry: CMPS outperforms 40.30% of its industry peers.
CMPS has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.49, CMPS is doing worse than 73.07% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Altman-Z -4.72
ROIC/WACCN/A
WACCN/A
CMPS Yearly LT Debt VS Equity VS FCFCMPS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

CMPS has a Current Ratio of 1.23. This is a normal value and indicates that CMPS is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.23, CMPS is not doing good in the industry: 85.88% of the companies in the same industry are doing better.
CMPS has a Quick Ratio of 1.23. This is a normal value and indicates that CMPS is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CMPS (1.23) is worse than 85.12% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.23
CMPS Yearly Current Assets VS Current LiabilitesCMPS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for CMPS have decreased strongly by -30.00% in the last year.
EPS 1Y (TTM)-30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-157.14%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, CMPS will show a small growth in Earnings Per Share. The EPS will grow by 5.73% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y34.49%
EPS Next 2Y15.15%
EPS Next 3Y10.76%
EPS Next 5Y5.73%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CMPS Yearly Revenue VS EstimatesCMPS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
CMPS Yearly EPS VS EstimatesCMPS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 2 -2 3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CMPS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CMPS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CMPS Price Earnings VS Forward Price EarningsCMPS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CMPS Per share dataCMPS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.15%
EPS Next 3Y10.76%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CMPS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COMPASS PATHWAYS PLC

NASDAQ:CMPS (11/10/2025, 12:34:49 PM)

5.66

+0.21 (+3.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners55.61%
Inst Owner Change4.13%
Ins Owners1.76%
Ins Owner Change-0.09%
Market Cap529.56M
Revenue(TTM)N/A
Net Income(TTM)-237.32M
Analysts82.5
Price Target15.91 (181.1%)
Short Float %6.75%
Short Ratio3.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-127.95%
Min EPS beat(2)-261.99%
Max EPS beat(2)6.08%
EPS beat(4)3
Avg EPS beat(4)-58.32%
Min EPS beat(4)-261.99%
Max EPS beat(4)20.36%
EPS beat(8)4
Avg EPS beat(8)-37.83%
EPS beat(12)6
Avg EPS beat(12)-28.62%
EPS beat(16)9
Avg EPS beat(16)-17.66%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.7%
PT rev (3m)1.01%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.45%
EPS NY rev (1m)1.46%
EPS NY rev (3m)8.36%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 14.09
P/tB 14.09
EV/EBITDA N/A
EPS(TTM)-2.86
EYN/A
EPS(NY)-1.55
Fwd EYN/A
FCF(TTM)-1.73
FCFYN/A
OCF(TTM)-1.73
OCFYN/A
SpS0
BVpS0.4
TBVpS0.4
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -92.84%
ROE -631.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-53.97%
ROA(5y)-43.08%
ROE(3y)-67.74%
ROE(5y)-51.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 1.23
Altman-Z -4.72
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)69.7%
Cap/Depr(5y)102.12%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-157.14%
EPS Next Y34.49%
EPS Next 2Y15.15%
EPS Next 3Y10.76%
EPS Next 5Y5.73%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-0.92%
EBIT Next 3Y-0.29%
EBIT Next 5Y7.15%
FCF growth 1Y-40.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-40.69%
OCF growth 3YN/A
OCF growth 5YN/A

COMPASS PATHWAYS PLC / CMPS FAQ

What is the fundamental rating for CMPS stock?

ChartMill assigns a fundamental rating of 1 / 10 to CMPS.


Can you provide the valuation status for COMPASS PATHWAYS PLC?

ChartMill assigns a valuation rating of 0 / 10 to COMPASS PATHWAYS PLC (CMPS). This can be considered as Overvalued.


What is the profitability of CMPS stock?

COMPASS PATHWAYS PLC (CMPS) has a profitability rating of 0 / 10.